150 related articles for article (PubMed ID: 36950803)
1. NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK.
Liu H; Lei W; Li Z; Wang X; Zhou L
J Cell Mol Med; 2023 Apr; 27(8):1069-1082. PubMed ID: 36950803
[TBL] [Abstract][Full Text] [Related]
2. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
[TBL] [Abstract][Full Text] [Related]
3. NR3C2 suppresses the proliferation, migration, invasion and angiogenesis of colon cancer cells by inhibiting the AKT/ERK signaling pathway.
Li J; Xu Z
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35191517
[TBL] [Abstract][Full Text] [Related]
4. RIG-I Promotes Cell Viability, Colony Formation, and Glucose Metabolism and Inhibits Cell Apoptosis in Colorectal Cancer by NF-
Liu Y; Ye S; Zhu Y; Chen L; Zhang Z
Dis Markers; 2022; 2022():1247007. PubMed ID: 35242239
[TBL] [Abstract][Full Text] [Related]
5. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
6. Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling.
Ou B; Sun H; Zhao J; Xu Z; Liu Y; Feng H; Peng Z
J Exp Clin Cancer Res; 2019 Oct; 38(1):426. PubMed ID: 31655629
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
Chen Y; Liu Y; Zhou Y; You H
Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
[TBL] [Abstract][Full Text] [Related]
9. Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/β-catenin signaling pathway.
Jiang J; Li Y; Jiang Z
Oncol Rep; 2019 Jun; 41(6):3281-3291. PubMed ID: 31002361
[TBL] [Abstract][Full Text] [Related]
10. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
Guo T; Peng S; Liu D; Li Y
Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
[TBL] [Abstract][Full Text] [Related]
11. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer.
Wang G; Yu Y; Wang YZ; Yin PH; Xu K; Zhang H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):1231-1249. PubMed ID: 32985258
[TBL] [Abstract][Full Text] [Related]
12. CircCDC6 restrains tumor growth and glycolysis energy metabolism in colorectal cancer via regulating miR-3187-3p and downstream PRKAA2.
Zhao C; Chen H; Min K
J Bioenerg Biomembr; 2022 Jun; 54(3):163-174. PubMed ID: 35438362
[TBL] [Abstract][Full Text] [Related]
13. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
[TBL] [Abstract][Full Text] [Related]
14. Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells.
Liu Q; Zhang L; Zou Y; Tao Y; Wang B; Li B; Liu R; Wang B; Ding L; Cui Q; Lin J; Mao B; Xiong W; Yu M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293209
[TBL] [Abstract][Full Text] [Related]
15. ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines.
Bai R; Shi Z; Zhang JW; Li D; Zhu YL; Zheng S
J Zhejiang Univ Sci B; 2012 Nov; 13(11):884-93. PubMed ID: 23125081
[TBL] [Abstract][Full Text] [Related]
16. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27
Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
[TBL] [Abstract][Full Text] [Related]
18. miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis.
Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
Biomed Pharmacother; 2017 Aug; 92():1119-1127. PubMed ID: 28622713
[TBL] [Abstract][Full Text] [Related]
19. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
[TBL] [Abstract][Full Text] [Related]
20. Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway.
Yu H; Xie Y; Zhou Z; Wu Z; Dai X; Xu B
Technol Cancer Res Treat; 2019; 18():1533033819870781. PubMed ID: 31888414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
